Citation Impact
Citing Papers
Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
2008 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Assays of different aspects of haemostasis – what do they measure?
2015 StandoutNobel
Static platelet adhesion, flow cytometry and serum TXB2 levels for monitoring platelet inhibiting treatment with ASA and clopidogrel in coronary artery disease: a randomised cross-over study
2009 StandoutNobel
Clopidogrel with or without Omeprazole in Coronary Artery Disease
2010 Standout
Universal Definition of Myocardial Infarction
2007 Standout
Genetic polymorphisms of the platelet receptors P2Y12, P2Y1 and GP IIIa and response to aspirin and clopidogrel
2006
Percutaneous coronary intervention: recommendations for good practice and training
2005
Haemostatic materials for wound healing applications
2021 Standout
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
2013 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Peri-Procedural Platelet Function and Platelet Inhibition in Percutaneous Coronary Intervention
2008
Platelet reactivity and nonresponse to dual antiplatelet therapy: A review
2009
Relation of Cytochrome P450 2C19 Loss-of-Function Polymorphism to Occurrence of Drug-Eluting Coronary Stent Thrombosis
2009
Electrospun mucosal wound dressings containing styptics for bleeding control
2018
Novel mechanism for sudden infant death syndrome: Persistent late sodium current secondary to mutations in caveolin-3
2006
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
The influence of clinical characteristics, laboratory and inflammatory markers on ‘high on-treatment platelet reactivity’ as measured with different platelet function tests
2009
Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10+12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients
2007
Coronary stents: A materials perspective
2006
Aspirin “resistance” and risk of cardiovascular morbidity: systematic review and meta-analysis
2008
Platelet Activation and Atherothrombosis
2007 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Frailty Assessment in the Cardiovascular Care of Older Adults
2013
Obesity and Altered Aspirin Pharmacology
2017
The development of binary Mg–Ca alloys for use as biodegradable materials within bone
2008 Standout
Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors
2011 Standout
The rise and fall of aspirin in the primary prevention of cardiovascular disease
2019
Aspirin and Antiplatelet Agent Resistance
2010
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Peri-procedural myocardial injury: 2005 update
2005
Atherosclerosis
2019 Standout
Enoxaparin versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention
2006
Third Universal Definition of Myocardial Infarction
2012 Standout
Aspirin Dose for the Prevention of Cardiovascular Disease
2007
On the mechanisms of biocompatibility
2008 Standout
Ultralow‐Fouling, Functionalizable, and Hydrolyzable Zwitterionic Materials and Their Derivatives for Biological Applications
2009 Standout
Aspirin resistance
2006
Current Options in Platelet Function Testing
2006
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study
2013
Treatment of Persistent Gross Hematuria with Tranexamic Acid in Autosomal Dominant Polycystic Kidney Disease
2017 Standout
The use of the VerifyNowsystem to monitor antiplatelet therapy: A review of the current evidence
2008
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Anti‐factor Xa kinetics after intravenous enoxaparin in patients undergoing percutaneous coronary intervention: a population model analysis
2005
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
Role of Reticulated Platelets and Platelet Size Heterogeneity on Platelet Activity After Dual Antiplatelet Therapy With Aspirin and Clopidogrel in Patients With Stable Coronary Artery Disease
2008
Aspirin resistance: position paper of the Working Group on Aspirin Resistance
2005
Measuring antiplatelet drug effects in the laboratory
2007
Development of new metallic alloys for biomedical applications
2012 Standout
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
2007 Standout
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
2011 Standout
Recent developments in stainless steels
2009 Standout
Patterned Hydrogels for Controlled Platelet Adhesion from Whole Blood and Plasma
2010 StandoutNobel
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
Platelet Function Testing in Cardiovascular Diseases
2004
Utility of the Aspirin and P2Y12 Response Assays to Determine the Effect of Antiplatelet Agents on Platelet Reactivity in Traumatic Brain Injury
2016
Dual antiplatelet drug resistance in patients with acute coronary syndrome.
2009
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Aspirin to Prevent Cardiovascular Disease: The Association of Aspirin Dose and Clopidogrel With Thrombosis and Bleeding
2009
Aspirin Resistance and Atherothrombotic Disease
2005
Manifestation of tranexamic acid toxicity in chronic kidney disease and kidney transplant patients: A report of four cases and review of literature
2016
Aspirin and Antiplatelet Agent Resistance
2010
Use of Aspirin and P2Y12 Response Assays in Detecting Reversal of Platelet Inhibition With Platelet Transfusion in Patients With Traumatic Brain Injury on Antiplatelet Therapy
2016
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Clinical Aspects of Platelet Inhibitors and Thrombus Formation
2007
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Poly(2-methacryloyloxyethyl phosphorylcholine) for Protein Conjugation
2008
Impact of Prior Use or Recent Withdrawal of Oral Antiplatelet Agents on Acute Coronary Syndromes
2004
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Part 14: Pediatric Advanced Life Support
2010 Standout
Conducting Meta-Analyses inRwith themetaforPackage
2010 Standout
Comparison of methods to evaluate clopidogrel-mediated platelet inhibition after percutaneous intervention with stent implantation
2009
Works of William Ng being referenced
Surgical Candidacy and Selection Biases in Nonemergent Left Main Stenting
2011
Incidence and predictors of upper gastrointestinal bleeding in patients receiving low-dose aspirin for secondary prevention of cardiovascular events in patients with coronary artery disease
2006
Tranexamic acid: a clinical review
2015
Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment
2004
Relation of Aspirin Resistance to Coronary Flow Reserve in Patients Undergoing Elective Percutaneous Coronary Intervention
2005
Cardiac arrhythmias as presenting symptoms in patients with limb-girdle muscular dystrophy
1997
Initial experience and safety in the treatment of chronic total coronary occlusions with a new optical coherent reflectometry-guided radiofrequency ablation guidewire
2003
Low-dose aspirin increases aspirin resistance in patients with coronary artery disease
2005
First human experience with angiopeptin-eluting stent: A quantitative coronary angiography and three-dimensional intravascular ultrasound study
2005
Aspirin Resistance and Adverse Clinical Events in Patients with Coronary Artery Disease
2007
Stable and optimal anticoagulation is achieved with a single dose of intravenous enoxaparin in patients undergoing percutaneous coronary intervention.
2002